IL17A and metabolic syndrome: In parallel, metabolic syndrome has also been shown to independently increase postoperative recurrence risk, accompanied by elevated eosinophil counts and enhanced IL-5 and IL-17A expression, with recurrence risk rising proportionally with the number of metabolic syndrome components [39].